Optinose is a specialty pharmaceutical company focused on creating and bringing to market innovative products for patients with diseases treated by ear, nose, and throat (ENT) and allergy specialists. Our mission is to improve the quality of life for patients. We are working to accomplish that by becoming the leading specialty healthcare company dedicated to creating innovative products that become standard of care for diseases cared for directly by, or in consultation with, ENT and allergy specialists. Our first product for these patients uses one of our patented Bi-Directional⢠Exhalation Delivery Systems (EDS) to uniquely deliver a potent steroid deep into the nose where inflammation can be hard to reach. Our EDS technology has other applications, such as in treatment of neurological or psychiatric disorders. Although these areas are not our focus, we have already successfully developed and out-licensed one product in that space, and plan to partner with organizations who focus on central nervous system treatments to develop more. Source
No articles found.
Lexicon Pharmaceuticals is a fully integrated biopharmaceutical company that is ap...
Lexicon Pharmaceuticals is a fully integrated b...
Founded in 2006 and headquartered in San Diego, Adamis (ADMP) is a specialty bioph...
Founded in 2006 and headquartered in San Diego,...
Magenta Therapeutics is a clinical-stage biotechnology company developing therapeu...
Magenta Therapeutics is a clinical-stage biotec...
Bayer is a global enterprise with core competencies in the life science fields of ...
Bayer is a global enterprise with core competen...
Seelos Therapeutics, Inc. (Nasdaq: SEEL) is a responsibly-driven company focused o...
Seelos Therapeutics, Inc. (Nasdaq: SEEL) is a r...
uniQure is delivering on the promise of gene therapy -- single treatments with pot...
uniQure is delivering on the promise of gene th...
Comtech Telecommunications Corp. designs, develops, produces and markets innovativ...
Comtech Telecommunications Corp. designs, devel...
Join the National Investor Network and get the latest information with your interests in mind.